MACROD2overexpression mediates estrogen independent growth and tamoxifen resistance in breast cancers
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MACROD2overexpression mediates estrogen independent growth and tamoxifen resistance in breast cancers
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 111, Issue 49, Pages 17606-17611
Publisher
Proceedings of the National Academy of Sciences
Online
2014-11-25
DOI
10.1073/pnas.1408650111
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Emergence of Constitutively Active Estrogen Receptor- Mutations in Pretreated Advanced Estrogen Receptor-Positive Breast Cancer
- (2014) R. Jeselsohn et al. CLINICAL CANCER RESEARCH
- D538G Mutation in Estrogen Receptor- : A Novel Mechanism for Acquired Endocrine Resistance in Breast Cancer
- (2013) K. Merenbakh-Lamin et al. CANCER RESEARCH
- ESR1 ligand-binding domain mutations in hormone-resistant breast cancer
- (2013) Weiyi Toy et al. NATURE GENETICS
- Activating ESR1 mutations in hormone-resistant metastatic breast cancer
- (2013) Dan R Robinson et al. NATURE GENETICS
- Macrodomain-containing proteins: regulating new intracellular functions of mono(ADP-ribosyl)ation
- (2013) Karla L. H. Feijs et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Macrodomain-containing proteins are new mono-ADP-ribosylhydrolases
- (2013) Florian Rosenthal et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Two Distinct Categories of Focal Deletions in Cancer Genomes
- (2013) Megha Rajaram et al. PLoS One
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer
- (2013) Alberto Bardelli et al. Cancer Discovery
- Endocrine-Therapy-Resistant ESR1 Variants Revealed by Genomic Characterization of Breast-Cancer-Derived Xenografts
- (2013) Shunqiang Li et al. Cell Reports
- Abstract 3372: Mouse keratinocyte side-population plays an important role during malignant progression to skin squamous cell carcinomas
- (2012) Sun Hye Kim et al. CANCER RESEARCH
- The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
- (2012) Christina Curtis et al. NATURE
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Androgen receptor expression is usually maintained in initial surgically resected breast cancer metastases but is often lost in end-stage metastases found at autopsy
- (2011) Ashley Cimino-Mathews et al. HUMAN PATHOLOGY
- Identification of Macrodomain Proteins as NovelO-Acetyl-ADP-ribose Deacetylases
- (2011) Dawei Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Tamoxifen downregulation of miR-451 increases 14-3-3ζ and promotes breast cancer cell survival and endocrine resistance
- (2011) A Bergamaschi et al. ONCOGENE
- The HOXB7 protein renders breast cancer cells resistant to tamoxifen through activation of the EGFR pathway
- (2011) K. Jin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Estrogen-Dependent and Estrogen-Independent Mechanisms Contribute to AIB1-Mediated Tumor Formation
- (2010) M. I. Torres-Arzayus et al. CANCER RESEARCH
- Signatures of mutation and selection in the cancer genome
- (2010) Graham R. Bignell et al. NATURE
- Knockin of mutant PIK3CA activates multiple oncogenic pathways
- (2009) John P. Gustin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of CDK10 as an Important Determinant of Resistance to Endocrine Therapy for Breast Cancer
- (2008) Elizabeth Iorns et al. CANCER CELL
- The single-macro domain protein LRP16 is an essential cofactor of androgen receptor
- (2008) J Yang et al. ENDOCRINE-RELATED CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search